Mumbai: P&G Health has appointed S Madhavan, an Independent Director of the company, as its new Chairperson, effective April 1, 2025. The decision was approved by the Board of Directors at its meeting held on February 12, 2025, as per the company’s stock exchange filing.
Madhavan will succeed Suresh Talwar, Independent Director and Chairperson, who will retire from the Board upon the completion of his second tenure on March 31, 2025. Additionally, Rani Ajit Jadhav, also an Independent Director, will step down from the Board on the same date.
The company stated in its regulatory filing, “In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that Mr. Suresh Talwar, Independent Director of the Company, shall retire from the Board on completion of their second tenure effective March 31, 2025.”
With an extensive background in finance, corporate governance, and leadership, S Madhavan brings a wealth of experience to his new role. His strategic insights and deep industry knowledge are expected to strengthen P&G Health’s governance and business trajectory.
